TCM
TNDM icon

Tributary Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Tributary Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,400
Closed -$744K – 212
2022
Q1 		$744K Sell
6,400
-8,000
-56% -$934K 0.06% 149
2021
Q4 		$2.17M Sell
14,400
-1,500
-9% -$202K 0.16% 105
2021
Q3 		$1.9M Buy
+15,900
New +$1.75M 0.15% 121

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Tributary Capital Management's TNDM Position: Q2 2022 in Review

Tributary Capital Management sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 6,400 shares — an estimated $744K sold.

Tributary Capital Management first reported a position in TNDM in Q3 2021 and held it in 3 quarters. The position peaked at $2.17M in Q4 2021. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

  • Tributary Capital Management reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
  • Tributary Capital Management sold 6,400 Tandem Diabetes Care shares in Q2 2022, an estimated $744K.
  • Tributary Capital Management first reported a position in Tandem Diabetes Care in Q3 2021 and held it in 3 quarters.
  • Tributary Capital Management's Tandem Diabetes Care position peaked at $2.17M in Q4 2021.
  • 330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Tributary Capital Management's 13F filing for Q2 2022, filed 19 Jul 2022.